Massachusetts Financial Services Co. MA lowered its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report) by 6.7% in the second quarter, HoldingsChannel reports. The institutional investor owned 813,107 shares of the company’s stock after selling 58,670 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Prestige Consumer Healthcare were worth $55,982,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Congress Wealth Management LLC DE raised its holdings in shares of Prestige Consumer Healthcare by 246.1% in the fourth quarter. Congress Wealth Management LLC DE now owns 114,220 shares of the company’s stock worth $6,993,000 after buying an additional 81,215 shares during the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of Prestige Consumer Healthcare by 5.3% during the fourth quarter. The Manufacturers Life Insurance Company now owns 605,376 shares of the company’s stock worth $37,061,000 after purchasing an additional 30,288 shares during the last quarter. State Board of Administration of Florida Retirement System raised its holdings in shares of Prestige Consumer Healthcare by 77.4% during the first quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock worth $1,830,000 after purchasing an additional 11,000 shares during the last quarter. Congress Asset Management Co. MA raised its holdings in shares of Prestige Consumer Healthcare by 596.2% during the fourth quarter. Congress Asset Management Co. MA now owns 679,256 shares of the company’s stock worth $41,584,000 after purchasing an additional 581,685 shares during the last quarter. Finally, Norges Bank purchased a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth $27,739,000. Hedge funds and other institutional investors own 99.95% of the company’s stock.
Prestige Consumer Healthcare Trading Up 0.6 %
Shares of Prestige Consumer Healthcare stock opened at $73.94 on Friday. Prestige Consumer Healthcare Inc. has a 1 year low of $56.34 and a 1 year high of $75.80. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The firm has a fifty day moving average price of $71.16 and a 200 day moving average price of $69.67. The stock has a market cap of $3.66 billion, a PE ratio of 17.73, a price-to-earnings-growth ratio of 2.06 and a beta of 0.48.
Wall Street Analyst Weigh In
Separately, DA Davidson raised their target price on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Wednesday, August 28th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $98.75.
Get Our Latest Stock Report on PBH
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Further Reading
- Five stocks we like better than Prestige Consumer Healthcare
- How Technical Indicators Can Help You Find Oversold Stocks
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- How to Find Undervalued Stocks
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- What is a support level?
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report).
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.